Skip to main content

Dragon's Blood

Scientific Name(s): Croton lechleri Muell. Arg.
Common Name(s): Blood of the dragon, Crofelemer, Drago, Dragon's blood, Sangre de drago, Sangre de grado, SP-303

Medically reviewed by Last updated on Jul 24, 2023.

Clinical Overview


Crofelemer, a single constituent of the C. lechleri tree, is approved by the US Food and Drug Administration (FDA) (brand name, Mytesi) for symptomatic relief of noninfectious diarrhea in patients with HIV/AIDS who are receiving antiretroviral therapy. A variety of traditional uses are associated with dragon's blood resin or sap, such as bleeding control, wound healing, and treatment of GI problems; however, evidence from clinical trials is insufficient to support these uses.


Clinical data are lacking to provide dosing recommendations for C. lechleri.


Contraindications have not been identified.


Information regarding safety and efficacy in pregnancy and lactation is lacking.


None well documented.

Adverse Reactions

No major toxic effects from consumption of C. lechleri extract have been reported. Systemic absorption of crofelemer is minimal, and studies report low levels of GI-related adverse effects (eg, abdominal pain, flatulence, dyspepsia).


Weak to no mutagenicity has been reported for the sap or essential oil of C. lechleri; however, the chemical constituent taspine is considered cytotoxic.

Scientific Family

  • Euphorbiaceae (spurge)


The genus Croton comprises approximately 750 species of trees and shrubs commonly found in tropical and subtropical regions. C. lechleri is a medium-sized tree that grows approximately 15 m in height, and the trunk is covered with smooth, mottled bark. When the bark is cut or damaged, it oozes a red, sap-like resin, which makes the tree appear to be bleeding. The plant has heart-shaped, alternate leaves 15 to 30 cm in width and length, as well as 3-celled fruits from small flowers borne on tall, thin spikes.(De Marino 2008, Gupta 2008, Jones 2003)

"Dragon's blood" is a name applied to many red resins described in medical literature. A number of alternative sources of "dragon's blood" are documented, including the genera Dracaena, Daemonorops, and Pterocarpus, as well as mercury sulfide.(Gupta 2008) Synonyms include Oxydectes lechleri and Croton draco.


Dragon's blood is mentioned in early Greek, Roman, and Arabic records; however, sources of preparations vary. Recorded use of "sangre de grado" (blood of the dragon) is extensive among Latin American countries, dating to the 1600s; both the bark and resin have been used internally and externally to stop bleeding, heal wounds, and treat GI problems (including piles and hemorrhoids).(Cobb 2014, Gupta 2008) The sap has also been used in vaginal baths before childbirth and as a remedy for cancer, as well as a pigment for artistic uses.(Alonso-Castro 2012, Duke 2002, Gonzales 2006, Gupta 2008)


Reviews of the chemical constituents of C. lechleri have been published.(Cobb 2014, Jones 2003)

Among other alkaloids, taspine has been isolated from C. lechleri sap, and sinoacutine has been isolated from the leaves.(De Marino 2008, Fayad 2009, Jones 2003) Proanthocyanidins (or oligomers) and flavonols are the major phenolic constituents of the sap of C. lechleri, including galloepicatechin, gallocatechin, epicatecin, and catechin.(Cai 1993a, Cai 1993b, Cai 1991, Cottreau 2012, Gonzales 2006) Diterpenes and steroidal compounds have also been described.(Jones 2003) The bark essential oil consists primarily of sequiterpenes and monoterpenes.(Rossi 2003) Crofelemer, a single constituent of the tree, has been approved by the FDA (brand name, Mytesi).

Uses and Pharmacology

Crofelemer is an antisecretory antidiarrheal proanthocyanidin oligomer extracted from the C. lechleri tree and is approved by the FDA for symptomatic relief of noninfectious diarrhea in patients with HIV/AIDS receiving antiretroviral therapy. Data in this monograph is mostly focused on use of the natural product C. lechleri (eg, sap, resin, plant extracts), primarily in animal and in vitro studies.(Frampton 2013, Hornby 2015)

Antibacterial/Antiviral effects

In vitro data

In in vitro studies, several phenolic compounds and diterpenes, as well as the essential oil from the plant, have demonstrated antibacterial activity.(Cai 1993a, Chen 1994, Rossi 2003)

The constituent taspine inhibited RNA-directed DNA polymerase activity from certain tumor virus types, including leukemia and sarcoma virus.(Gupta 2008, Sethi 1977)

Antioxidant activity

Antioxidant properties have been described for C. lechleri sap.(Gupta 2008, Lopes 2004, Rossi 2003)

C. lechleri sap has an exceptionally high and stable antioxidant content (at least 93% inhibition percentage of 2,2-diphenyl-1-picrylhydrazyl [DPPH]), suggesting a potential role as an antioxidant agent or ingredient for consumer product formulations (eg, food, pharmaceuticals, nutraceuticals or cosmetics, paint or paper products).(Escobar 2018)

Avulsed teeth replantation

A 10% C. lechlerisap was found to be an effective medium to preserve viability of teeth for replantation.(Martins 2016)


Animal and in vitro data

C. lechleri extracts increased apoptosis in Helen Lake tumor cell and other human cancer cell lines, and have inhibited tumor growth in mice.(Alonso-Castro 2012, Gonzales 2006, Gupta 2008, Montopoli 2012) Thaspine (taspine), a topoisomerase inhibitor, alone induced apoptosis in mouse models of colon cancer.(Fayad 2009) An inhibitory effect against mutagens has been demonstrated in vitro.(Gonzales 2006)

Conversely, leukemic cells from children were exposed to C. lechleri extracts and showed resistance to the extract and increased survival times.(Styczynski 2006)


Animal data

Experiments in mice have shown that C. lechleri sap has activity on gastric smooth muscle cells.(Froldi 2009)

GI effects

Animal data

Reductions in the size of induced gastric ulcers in rats were achieved when sap from C. lechleri and Croton palanostigma was added to the rats' drinking water for 7 days. A decrease in bacterial counts of ulcers in the sap-drinking rats versus controls was also reported.(Jones 2003)

Immunomodulatory activity

In vitro data

An in vitro study demonstrated immunomodulatory activity of sangre de drago, with potent inhibitory activity on classical and alternative pathways of the complement system and inhibition of proliferation of activated T cells.(Gupta 2008)

Wound-healing effects

Animal and in vitro data

Anti-inflammatory properties have been described for C. lechleri sap. Anti-inflammatory actions of the taspine alkaloid from dragon's blood were first documented in 1979.(Perdue 1979) Later studies confirmed these actions, leading to further studies regarding wound healing. In one study, taspine was found to be the active cicatrizant principle by an in vivo test in mice; increased migration of human fibroblasts was suggested as the probable mechanism in this acceleration of the wound-healing process.(Vaisberg 1989) Another report evaluating taspine's wound-healing properties demonstrated positive results (with higher dosing, results were seen earlier rather than later) using such parameters as wound tensile strength and histology; taspine also stimulated chemotaxis for fibroblasts. Data from the report suggest that taspine promotes early phases of wound healing in a dose-dependent manner.(Porras-Reyes 1993) Another chemical constituent, a dihydrobenzofuran lignan also involved in wound healing actions, was isolated in 1993.(Pieters 1993) Additionally, an in vitro study evaluating the effect of C. lechleri sap demonstrated inhibition of cutaneous neurogenic inflammation.(Pereira 2010)

Clinical data

Clinical data regarding the use of C. lechleri sap for wound healing are lacking. C. lechleri offers limited use in dermatology and further investigations are necessary to gain additional insight into its potential clinical usefulness.(Pona 2019)


Clinical data are lacking to provide dosing recommendations.

Pregnancy / Lactation

Information regarding safety and efficacy in pregnancy and lactation is lacking. C. lechleri sap has been traditionally used as a vaginal bath before childbirth and for healing after an abortion; however, clinical data are insufficient to support these uses.(Duke 2002, Gupta 2008, Jones 2003)


Case reports for interactions with C. lechleri extracts are lacking.

Adverse Reactions

No major toxic effects have been reported from consumption of C. lechleri extract, and studies evaluating crofelemer report low levels of GI-related adverse effects (eg, abdominal pain, flatulence, dyspepsia).(Clay 2014, Cottreau 2012)


Weak mutagenicity in Salmonella and yeast tests has been reported for the sap of C. lechleri(Jones 2003, Lopes 2004); in an Ames test employing Salmonella typhimurium, no mutagenicity of the plant essential oil was observed.(Rossi 2011) Because the constituent taspine may be cytotoxic, it should not exceed 5,000 ppm.(Itokawa 1991, Jones 2003, Vaisberg 1989) The acute oral median lethal dose of crofelemer in rats was determined to be greater than 300 mg/kg.(Jones 2003) Chronic mouse skin carcinogenesis models found no evidence of mutagenicity in topical sap applications.(Jones 2003)

Index Terms

  • Croton draco
  • Oxydectes lechleri



This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

More about dragon's blood

Related treatment guides

Alonso-Castro AJ, Ortiz-Sánchez E, Domínguez F, et al. Antitumor effect of Croton lechleri Mull. Arg. (Euphorbiaceae). J Ethnopharmacol. 2012;140(2):438-442.22301443
Cai Y, Chen ZP, Phillipson JD. Clerodane diterpenoids from Croton lechleri. Phytochemistry. 1993;34(1):265-268.
Cai Y, Chen ZP, Phillipson JD. Diterpenes from Croton lechleri. Phytochemistry. 1993;32(3):755-760.
Cai Y, Evans FJ, Roberts MF, Phillipson JD, Zenk MH, Gleba YY. Polyphenolic compounds from Croton lechleri. Phytochemistry. 1991;30(6):2033-2040.
Chen ZP, Cai Y, Phillipson JD. Studies on the anti-tumour, anti-bacterial, and wound-healing properties of dragon's blood. Planta Med. 1994;60(6):541-545.7809208
Clay PG, Crutchley RD. Noninfectious diarrhea in HIV seropositive individuals: a review of prevalence rates, etiology, and management in the era of combination antiretroviral therapy. Infect Dis Ther. 2014;3(2):103-122.25388760
Cobb C, Goldwhite H, Fetterolf M. The Chemistry of Alchemy: From Dragon's Blood to Donkey Dung, How Chemistry Was Forged. Amherst, NY: Prometheus Books; 2014.
Cottreau J, Tucker A, Crutchley R, Garey KW. Crofelemer for the treatment of secretory diarrhea. Expert Rev Gastroenterol Hepatol. 2012;6(1):17-23.22149578
De Marino S, Gala F, Zollo F, et al. Identification of minor secondary metabolites from the latex of Croton lechleri (Muell-Arg) and evaluation of their antioxidant activity. Molecules. 2008;13(6):1219-1229.18596648
Duke JA, Bogenschutz-Godwin MJ, duCellier J, Duke PK. Handbook of Medicinal Herbs. 2nd ed. CRC Press; 2002.
Escobar JD, Prieto C, Pardo-Figuerez M, Lagaron JM. Dragon's blood sap: storage stability and antioxidant activity. Molecules. 2018;23(10):2641. doi:10.3390/molecules2310264130326562
Fayad W, Fryknäs M, Brnjic S, Olofsson MH, Larsson R, Linder S. Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters. PLoS One. 2009;4(10):e7238.19798419
Frampton JE. Crofelemer: a review of its use in the management of non-infectious diarrhoea in adult patients with HIV/AIDS on antiretroviral therapy. Drugs. 2013;73(10):1121-1129.23807722
Froldi G, Zagotto G, Filippini R, Montopoli M, Dorigo P, Caparrotta L. Activity of sap from Croton lechleri on rat vascular and gastric smooth muscles. Phytomedicine. 2009;16(8):768-775.19406630
Gonzales GF, Valerio LG Jr. Medicinal plants from Peru: a review of plants as potential agents against cancer. Anticancer Agents Med Chem. 2006;6(5):429-444.17017852
Gupta D, Bleakley B, Gupta RK. Dragon's blood: Botany, chemistry and therapeutic uses. J Ethnopharmacol. 2008;115(3):361-380.18060708
Hornby PJ. Drug discovery approaches to irritable bowel syndrome. Expert Opin Drug Discov. 2015;10(8):809-824. doi:10.1517/17460441.2015.104952826193876
Itokawa H, Ichihara Y, Mochizuki M, et al. A cytotoxic substance from Sangre de Grado. Chem Pharm Bull (Tokyo). 1991;39(4):1041-1042.1893488
Jones K. Review of sangre de drago (Croton lechleri)--a South American tree sap in the treatment of diarrhea, inflammation, insect bites, viral infections, and wounds: traditional uses to clinical research. J Altern Complement Med. 2003;9(6):877-896.14736360
Lopes MI, Saffi J, Echeverrigaray S, Henriques JA, Salvador M. Mutagenic and antioxidant activities of Croton lechleri sap in biological systems. J Ethnopharmacol. 2004;95(2-3):437-445.15507372
Martins CM, Hamanaka EF, Hoshida TY, et al. Dragon's blood sap (Croton lechleri) as storage medium for avulsed teeth: in vitro study of cell viability. Braz Dent J. 2016;27(6):751-756. doi:10.1590/0103-644020160098727982190
Montopoli M, Bertin R, Chen Z, Bolcato J, Caparrotta L, Froldi G. Croton lechleri sap and isolated alkaloid taspine exhibit inhibition against human melanoma SK23 and colon cancer HT29 cell lines. J Ethnopharmacol. 2012;144(3):747-753.23123266
Perdue GP, Blomster RN, Blake DA, Farnsworth NR. South American plants II: taspine isolation and anti-inflammatory activity. J Pharm Sci. 1979;68(1):124-126.758452
Pereira U, Garcia-Le Gal C, Le Gal G, et al. Effects of sangre de drago in an in vitro model of cutaneous neurogenic inflammation. Exp Dermatol. 2010;19(9):796-799.20698880
Pieters L, de Bruyne T, Claeys M, et al. Isolation of a dihydrobenzofuran lignan from South American dragon's blood (Croton spp.) as an inhibitor of cell proliferation. J Nat Prod. 1993;56(6):899-906.8350090
Pona A, Cline A, Kolli SS, Taylor SL, Feldman SR. Review of future insights of dragon's blood in dermatology. Dermatol Ther. 2019;32(2):e12786. doi:10.1111/dth.1278630556246
Porras-Reyes BH, Lewis WH, Roman J, Simchowitz L, Mustoe TA. Enhancement of wound healing by the alkaloid taspine defining mechanism of action. Proc Soc Exp Biol Med. 1993;203(1):18-25.8386382
Rossi D, Bruni R, Bianchi N, et al. Evaluation of the mutagenic, antimutagenic and antiproliferative potential of Croton lechleri (Muell. Arg.) latex. Phytomedicine. 2003;10(2-3):139-144.12725567
Rossi D, Guerrini Am Maietti S, et al. Chemical fingerprinting and bioactivity of Amazonian Ecuador Croton lechleri Mull. Arg. (Euphorbiaceae) stem bark essential oil: A new functional food ingredient? Food Chem. 2011;126(3):837-848. doi:10.1016/j.foodchem.2010.11.042
Sethi M. Inhibition of RNA-directed DNA polymerase activity of RNA tumor viruses by taspine. Can J Pharm Sci. 1977;12(1):7-9.833729
Styczynski J, Wysocki M. Alternative medicine remedies might stimulate viability of leukemic cells. Pediatr Blood Cancer. 2006;46(1):94-98.16047362
Vaisberg AJ, Milla M, Planas MC, et al. Taspine is the cicatrizant principle in Sangre de Grado extracted from Croton lechleri. Planta Med. 1989;55(2):140-143.2748730

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.